Skip to main content

UBS Group AG

Position in ALT — Altimmune, Inc.

CIK 1610520 ZURICH, V8

Position in ALT

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$2,633,808
-$152,876 QoQ
Shares Held
866,385
-4.2% QoQ
Ownership
0.445%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#25
of 210 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 98% Shared 0% None 2%

Common Shares in ALT Over Time

Shares Held

Position Value (USD)

Derivatives in ALT

reported options exposure · as of Dec 31, 2025
CallValue
$994,555
CallShares
275,500
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

UBS Group AG holds $8,789,681,375 across 562 Biotechnology names. ALT ranks #193 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in ALT

Export CSV
30 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,633,808 866,385
2026-03-31 $2,786,684 904,768
2025-12-31 $994,555 275,500
2025-12-31 $2,317,792 642,048
2025-09-30 $1,077,843 285,900
2025-09-30 $2,423,494 642,837
2025-06-30 $3,432,371 886,918
2025-03-31 $3,940,825 788,165
2024-12-31 $5,187,991 719,555
2024-09-30 $1,734,273 282,455
2024-06-30 $1,061,346 159,601
2024-03-31 $4,988,210 490,001
2023-12-31 $655,425 58,260
2023-09-30 $63,065 24,256
2023-06-30 $65,523 18,562
2023-03-31 $684,474 162,198
2022-12-31 $6,301,484 383,069
2022-09-30 $103,437 8,100
2022-09-30 $718,657 56,277
2022-09-30 $84,282 6,600
2022-06-30 $5,943 508
2022-03-31 $12,228 2,008
2021-12-31 $1,601,607 174,848
2021-09-30 $1,150,702 101,742
2021-06-30 $336,722 34,185
2021-03-31 $1,297,514 91,827
2020-12-31 $15,811,062 1,401,690
2020-09-30 $15,932 1,207
2020-06-30 $403,177 37,645
2020-03-31 $1,605 500